Use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection, and composition for inhibiting transplant rejection
CA 2018287 C · Owner: Calne, Roy · Inventors: Calne, Roy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection in a mammal in need thereof and, comprising in association with an appropriate pharmaceutically acceptable carrier, rapamycin in an appropriate amount to be administrable to said mammal in a mammal rejection inhibiting amount. The invention also relates to a composition for inhibiting organ or tissue transplant rejection in a mammal in need thereof comprising, (a) an amount of rapamycin in combination with (b) an amount of one or more other chemotherapeutic agents for inhibiting transplant rejection, said amounts of (a) and (b) together being effective to inhibit …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 1990 and granted November 20, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 5, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.